Niquitin Przezroczysty (Nicotine)

Nicotine in the patch is absorbed into the bloodstream and acts as an agonist at nicotinic acetylcholine receptors in the brain. This continuous stimulation lessens the intensity of withdrawal symptoms and cravings associated with nicotine dependence, supporting the quitting process.

The appropriate dose is determined by the prescribing healthcare professional based on the individual’s smoking history and dependence level. The prescriber selects the patch strength and duration; patients should not adjust the dose or frequency without medical advice.

Safety of nicotine patches in pregnancy or lactation has not been definitively established. Use is generally avoided unless the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Compared with oral nicotine replacement (gum, lozenges) and inhalers, the patch provides a steady, controlled nicotine delivery without the need for frequent dosing. Unlike prescription medications such as varenicline, it does not act on dopamine receptors, which may result in a different side‑effect profile. Choice depends on patient preference, medical history and clinician recommendation.

Store the patches at room temperature, below 25 °C, in the original packaging. Keep them away from moisture, direct sunlight and heat sources. Do not refrigerate or freeze the product, as temperature extremes can affect adhesive properties and nicotine stability.

Apply the patch to clean, dry, hair‑free skin on the upper arm, chest, or back. Remove the protective backing, press firmly for several seconds, and leave the patch in place for the prescribed duration (usually 24 hours). Rotate application sites each day to reduce skin irritation, and discard the patch after use.

Serious risks include allergic reactions such as rash, swelling or hives, and cardiovascular events like chest pain, arrhythmia or hypertension, especially in patients with pre‑existing heart disease. If any severe symptoms occur, the patch should be removed immediately and medical attention sought.

The patch should not be used by individuals with known hypersensitivity to nicotine or patch components, recent myocardial infarction or unstable angina, uncontrolled hypertension, severe skin disorders at the application site, or by pregnant or breastfeeding women unless specifically advised by a healthcare professional.